Details for New Drug Application (NDA): 216852
✉ Email this page to a colleague
The generic ingredient in PHYTONADIONE is phytonadione. There are ten drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for 216852
| Tradename: | PHYTONADIONE |
| Applicant: | Baxter Hlthcare Corp |
| Ingredient: | phytonadione |
| Patents: | 0 |
Pharmacology for NDA: 216852
| Physiological Effect | Increased Prothrombin Activity Reversed Anticoagulation Activity |
Suppliers and Packaging for NDA: 216852
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 216852 | ANDA | Baxter Healthcare Corporation | 43066-132 | 43066-132-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (43066-132-10) / .5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/0.5ML | ||||
| Approval Date: | Feb 26, 2026 | TE: | AB2 | RLD: | No | ||||
Complete Access Available with Subscription
